Indirect comparison of efficacy and safety data in atrial fibrillation patients treated with apixaban (Aristotle study) versus dabigatran (rely study) based on chads2 score stratification

Authors
Category Primary study
JournalCirculation: Cardiovascular Quality and Outcomes
Year 2013
This article has no abstract
Epistemonikos ID: a5a25bd4eeb6a774ffcba495e4f00d05bc862151
First added on: Feb 05, 2025